EU Renews Moderna’s Spikevax Approval, Clarifies Stance On Comirnaty Booster
Executive Summary
The European Medicines Agency has explained the grounds for its decision to recommend an extension of the approval for Moderna’s coronavirus vaccine, and why it differed from the US FDA in its advice on a booster dose of the Pfizer/BioNTech product.